Sun Pharma Advanced Research Co Ltd SPARC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 218.65
- Day Range
- INR 215.60–220.00
- 52-Week Range
- INR 178.80–472.80
- Bid/Ask
- INR 216.30 / INR 216.30
- Market Cap
- INR 70.19 Bil
- Volume/Avg
- 460,922 / 995,727
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 65.65
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 407
- Website
- https://www.sparc.life
Comparables
Valuation
|
Metric
|
SPARC
|
543434
|
524348
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 24.80 | 25.96 |
Price/Book Value | 21.16 | 4.03 | 3.44 |
Price/Sales | 65.65 | 5.57 | 1.75 |
Price/Cash Flow | — | 28.33 | 19.64 |
Price/Earnings
SPARC
543434
524348
Financial Strength
|
Metric
|
SPARC
|
543434
|
524348
|
|---|---|---|---|
Quick Ratio | 1.93 | 3.14 | 0.91 |
Current Ratio | 2.08 | 6.26 | 1.66 |
Interest Coverage | −371.99 | 192.48 | 8.03 |
Quick Ratio
SPARC
543434
524348
Profitability
|
Metric
|
SPARC
|
543434
|
524348
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | 7.10% |
Return on Equity (Normalized) | — | — | 13.89% |
Return on Invested Capital (Normalized) | — | — | 10.74% |
Return on Assets
SPARC
543434
524348
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Xtbfcsytfk | Nrjqk | $79.9 Bil | |
ZTS
| Zoetis Inc Class A | Nzpnqgmjd | Hjpx | $79.3 Bil | |
HLN
| Haleon PLC ADR | Jksgpnwn | Ncx | $38.1 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Hvfvzrjc | Cndt | $18.9 Bil | |
VTRS
| Viatris Inc | Kphgpqwm | Tjwdw | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Qmmchbdd | Ppfp | $11.7 Bil | |
CTLT
| Catalent Inc | Shsrkgnr | Vycncrq | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Vtfzmglg | Cjvnw | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Jktcfkj | Rzzt | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Jrmqwwcv | Ndvjynz | $3.2 Bil |